Artificial bone 3D printing company Osteopore (ASX: OSX) burst onto the stock market this week, its shares rising rising four times in price on debut.
The company’s shares rose a further 10 cents in its second day of trading.
The Perth and Singaporean company, which prints bone scaffold implants designed to fit individual patients, raised $5.25 million and is now valued at more than $20 million.
Osteopoplug, Osteomesh and Osteostrips are manufactured in-house using 3D printing technology that is precise and allows for customisation of shape and geometry.
In association with surgical techniques the implants encourage bone growth and then are reabsorbed into the blood system.
The companies products are already on sale internationally, with the new funds raised to be used to boost global marketing.
Product offerings will also be broadened into dental, orthopaedic and long bone offerings.
Executive director, Geoff Pocock said: “Our focus now is on execution of our business plan to build value in the company for shareholders.”
Subscribe to our free @AuManufacturing newsletter here.